SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-03-012534
Filing Date
2003-11-12
Accepted
2003-11-12 15:24:34
Documents
7
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y91481e10vq.htm 10-Q 368110
3 COLLABORATION AGREEMENT y91481exv10w26.htm EX-10.26 371666
4 STOCK PURCHASE AGREEMENT y91481exv10w27.htm EX-10.27 60051
5 NON-EXCLUSIVE PATENT LICENSE AGREEMENT y91481exv10w28.htm EX-10.28 84611
6 INDEPENDENT ACCOUNTANT'S PREFERABILITY LETTER y91481exv18w1.htm EX-18.1 2445
7 302 CERTIFICATION OF CEO AND CFO y91481exv31.htm EX-31 15496
8 906 CERTIFICATION OF CEO AND CFO y91481exv32.htm EX-32 2277
  Complete submission text file 0000950123-03-012534.txt   906867
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 03993436
SIC: 2834 Pharmaceutical Preparations